These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15797660)

  • 21. Level of blood pressure control in a hypertensive population when measurements are performed outside the clinical setting.
    Félix-Redondo FJ; Fernández-Bergés D; Espinosa-Garcia J; Pozuelos-Estrada J; Molina-Martínez LM; Pérez-Castán JF; Ríos-Rivera J; Valiente-Rubio JI; Gómez-de-la-Cámara A; Rodríguez-Pascual N
    Cardiol J; 2009; 16(1):57-67. PubMed ID: 19130417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: a prospective, randomized, open-label, blinded end-point trial.
    Hermida RC; Ayala DE; Khder Y; Calvo C
    Clin Ther; 2008 Jan; 30(1):108-20. PubMed ID: 18343247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of semiautomatic clinic and 24-h ambulatory blood pressure measurements to evaluate combination therapy: the Ramipril-Hydrochlorothiazide Hypertension trial.
    White WB; Cleveland JM; Rolleri RL;
    J Hum Hypertens; 2008 Aug; 22(8):559-68. PubMed ID: 18463672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors influencing white-coat effect.
    Manios ED; Koroboki EA; Tsivgoulis GK; Spengos KM; Spiliopoulou IK; Brodie FG; Vemmos KN; Zakopoulos NA
    Am J Hypertens; 2008 Feb; 21(2):153-8. PubMed ID: 18174883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self blood pressure monitoring: a worthy substitute for ambulatory blood pressure?
    McGowan N; Padfield PL
    J Hum Hypertens; 2010 Dec; 24(12):801-6. PubMed ID: 20164849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of manidipine/delapril versus losartan/hydrochlorothiazide fixed combinations in patients with hypertension and diabetes.
    Roca-Cusachs A; Schmieder RE; Triposkiadis F; Wenzel RR; Laurent S; Kohlmann O; Fogari R;
    J Hypertens; 2008 Apr; 26(4):813-8. PubMed ID: 18327093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.
    Kim SH; Chung WY; Zo JH; Kim MA; Chang HJ; Cho YS; Youn TJ; Chae IH; Choi DJ; Gwak JJ; Lee HY; Park JS; Kang HJ; Kim YJ; Kim HS
    Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of home measurement and ambulatory monitoring of blood pressure in the adjustment of antihypertensive treatment.
    Niiranen TJ; Kantola IM; Vesalainen R; Johansson J; Ruuska MJ
    Am J Hypertens; 2006 May; 19(5):468-74. PubMed ID: 16647616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reproducibility of the circadian blood pressure pattern in 24-h versus 48-h recordings: the Spanish Ambulatory Blood Pressure Monitoring Registry.
    Hernández-del Rey R; Martin-Baranera M; Sobrino J; Gorostidi M; Vinyoles E; Sierra C; Segura J; Coca A; Ruilope LM;
    J Hypertens; 2007 Dec; 25(12):2406-12. PubMed ID: 17984661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood pressure assessment in haemodialysis patients: comparison between pre-dialysis blood pressure and ambulatory blood pressure measurement.
    Fagugli RM; Ricciardi D; Rossi D; De Gaetano A; Taglioni C
    Nephrology (Carlton); 2009 Apr; 14(3):283-90. PubMed ID: 19444959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension.
    Mistry GC; Maes AL; Lasseter KC; Davies MJ; Gottesdiener KM; Wagner JA; Herman GA
    J Clin Pharmacol; 2008 May; 48(5):592-8. PubMed ID: 18353996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
    Abe M; Okada K; Maruyama T; Matsumoto K
    Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study of the clinically useful interval in ambulatory monitoring of blood pressure].
    Mora-Maciá J; Agraz Pamplona I; Ocón Pujadas J; Barceló P
    Med Clin (Barc); 1997 Feb; 108(7):248-53. PubMed ID: 9121192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct comparison of repeated same-day self and ambulatory blood pressure monitoring.
    Carney S; Gillies A; Garvey L; Smith A
    Nephrology (Carlton); 2005 Apr; 10(2):151-6. PubMed ID: 15877675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The trained observer better predicts daytime ABPM diastolic blood pressure in hypertensive patients than does an automated (Omron) device.
    Graves JW; Grossardt BR; Gullerud RE; Bailey KR; Feldstein J
    Blood Press Monit; 2006 Apr; 11(2):53-8. PubMed ID: 16534405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12-month randomized, double-blind comparator trial with hydrochlorothiazide.
    Schmieder RE; Philipp T; Guerediaga J; Gorostidi M; Smith B; Weissbach N; Maboudian M; Botha J; van Ingen H
    Circulation; 2009 Jan; 119(3):417-25. PubMed ID: 19139391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension.
    Gleim GW; Rubino J; Zhang H; Shahinfar S; Soffer BA; Lyle PA; Littlejohn TW; Feig PU
    Clin Ther; 2006 Oct; 28(10):1639-48. PubMed ID: 17157119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Blood pressure assessment in normoreactive and hyperreactive patients. A comparative study between casual and ambulatory blood pressure monitoring].
    Marsaro EA; Vasquez EC; Lima EG
    Arq Bras Cardiol; 1996 Nov; 67(5):319-24. PubMed ID: 9239866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients.
    Fogari R; Mugellini A; Zoppi A; Lazzari P; Destro M; Rinaldi A; Preti P
    J Hum Hypertens; 2006 Mar; 20(3):177-85. PubMed ID: 16306998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.